PolyHeme FDA Approval Status
FDA Approved: No
Brand name: PolyHeme
Generic name: human hemoglobin
Company: Northfield Laboratories Inc.
Treatment for: Bleeding Disorder
PolyHeme is a human hemoglobin-based red cell substitute for the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available.
Development timeline for PolyHeme
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
